Despite the decline in profit, the results exceeded Street expectations, with net profit surpassing the estimated Rs 1,195 ...

Brokerages are optimistic about UltraTech Cement, citing strong Q3 recovery, better demand outlook, and government ...

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Join us on the UltraTech Cem Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in the know with the latest information about UltraTech Cem, including ...

Shares of firms like ICICI Bank, IndiGo, NTPC, UltraTech, Adani Wilmar, and others will be in focus on Friday's trade ...

Following Q3 earnings, UltraTech Cement remains top cement pick of several brokerages. They remain bullish on the stock given ...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes HPCL, Indus ...

Dr Reddy's Laboratories reported its consolidated Q3 results with a 2.5 per cent rise in profit to Rs 1,413.3 crore compared to Rs 1,378.9 crore in the same period last year ...

Moody's indicates that most Indian companies are shielded from rupee depreciation because of mitigating factors, whereas govt-owned oil marketing comp ...

Stock to watch today; focus on key Q3 earnings and stock movements. Explore the detailed performance of stocks like Adani ...

UltraTech Cement’s margins shrank in Q3 despite revenue growth and falling fuel costs, but analysts had expected a worse hit.

Ultratech Cement is expected to report a YoY decline in its profitability in the December quarter, owing to lower realization ...